From Name:
From Email:
To Name:
To Email:

Optional Message:

Access Denied: Stem Cell Therapy Shows Some Promise in Refractory Angina, but Patients Can't Get It

from TCTMD

Despite new data showing that stem cell therapy has the potential to improve exercise time and reduce mortality in patients with refractory angina, researchers said at the Society for Cardiovascular Angiography and Interventions 2017 Scientific Sessions that the option is all but dead due to withdrawal of financial support, resulting in patients being denied access to a promising treatment. Presenting a summation of all the data that have been collected over the last decade on the use of autologous CD34+ cells to treat patients with class III or IV angina despite optimal medical therapy, Thomas Povsic, MD, PhD, said this group of patients is in dire need of new treatment options, and maintained that "it is imperative to explore methods to bring this therapy to patients." more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063